| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $161.6M | +13.5% |
| Cost of Revenue | $149.7M | +60.2% |
| Gross Profit | $11.9M | -75.7% |
| R&D Expense | $10.6M | +46.7% |
| SG&A Expense | $14.3M | +33.1% |
| Operating Income | -$33.5M | -394.3% |
| Pre-tax Income | -$33.4M | -391.2% |
| Income Tax | $1K | -100.0% |
| Net Income | -$33.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.0M | -47.5% |
| Accounts Receivable | $8.2M | -35.2% |
| Inventory | $10.7M | -31.8% |
| Current Assets | $63.8M | -27.4% |
| Total Assets | $67.3M | -26.2% |
| Current Liabilities | $38.1M | +7.6% |
| Total Liabilities | $40.1M | +8.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.0M | -349.6% |
| Capital Expenditures | $467K | -10.2% |
| Investing Cash Flow | -$467K | +10.2% |
| Financing Cash Flow | $594K | -98.4% |
| Free Cash Flow | -$15.5M | -381.8% |
| -790.7% |
| EPS (Basic) | -$0.14 | -800.0% |
| EPS (Diluted) | -$0.14 | -800.0% |
| Stockholders' Equity |
| $27.2M |
| -49.6% |